Calprotectin blood test - FAQ series

05. May 2021 | 4 min read

Calprotectin blood test - FAQ series

Plasma and serum calprotectin

In our Frequently Asked Questions about calprotectin series we will answer questions we often receive about plasma and serum calprotectin and the Gentian Calprotectin Immunoassay GCAL®.

If you have any additional questions don't hesitate to contact us on marketing@gentian.com.

Learn more about calprotectin in blood:

 

What type of assay is the Gentian Calprotectin Immunoassay GCAL®?

What is calprotectin’s role in neutrophil activation?

What is the value of calprotectin in blood as biomarker in IBD?

What is the clinical value of calprotectin in sepsis & severe infections?

Is calprotectin upregulated in sepsis in COVID-19?

What role can plasma & serum calprotectin play in severe COVID-19?

How is calprotectin useful to monitor treatment response in rheumatoid arthritis?

How is calprotectin useful in clinical assessment of rheumatoid arthritis?

What is the value of calprotectin in JIA & Still's disease?

 

 

GCAL® Advantages

advanteges_web-ready

Get in touch

For more details about the Gentian Calprotectin Immunoassay GCAL®  please contact us at marketing@gentian.com or fill out the form below:

 

You may also read


Mini-webinar: eGFR equations for multi-ethnic Asian populations

Mar 18, 2024

Mini-webinar: eGFR equations for multi-ethnic Asian populations

In the series of mini-webinars on cystatin C and kidney health our Global Product Manager for Cystatin C Mr...

KDIGO – Recommends increased use of cystatin C in addition to creatinine

Mar 13, 2024

KDIGO – Recommends increased use of cystatin C in addition to creatinine

The international organisation KDIGO (Kidney Disease: Improving Global Outcomes) has published the 2024..

Meet us at «Veterinærdagene» to learn about Canine CRP (Nordic Event)

Mar 05, 2024

Meet us at «Veterinærdagene» to learn about Canine CRP (Nordic Event)

Meet us at «Veterinærdagene» - the Annual Veterinary days in Norway Our Canine CRP team looks forward to..